Improving HIV prevention for postpartum women in Malawi

Project 2 - Improving HIV prevention among postpartum women in Lilongwe, Malawi: the postpartum prevention package [Parent Title: PREVENTING INFANT INFECTIONS WITH IMPLEMENTATION SCIENCE IN MALAWI]

['FUNDING_P01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-11063848

This study is looking at ways to help new moms in Malawi stay safe from HIV after giving birth by providing them with easy access to a prevention method called PrEP, along with support and education to make sure they can use it effectively for their health and their baby's health.

Quick facts

Phase['FUNDING_P01']
Study typeNih_funding
SexAll
SponsorUNIV OF NORTH CAROLINA CHAPEL HILL (nih funded)
Locations1 site (CHAPEL HILL, UNITED STATES)
Trial IDNIH-11063848 on ClinicalTrials.gov

What this research studies

This research focuses on enhancing HIV prevention strategies for women who have recently given birth in Malawi, where the risk of acquiring HIV during the postpartum period is notably high. The project aims to implement a postpartum prevention package that includes the use of pre-exposure prophylaxis (PrEP), which can significantly reduce the risk of HIV transmission. By addressing barriers to PrEP uptake and adherence, the research seeks to improve health outcomes for both mothers and their infants. The approach includes community engagement and education to ensure that women understand and can access these preventive measures effectively.

Who could benefit from this research

Good fit: Ideal candidates for this research are postpartum women in Malawi who are at risk of acquiring HIV during the breastfeeding period.

Not a fit: Patients who are not postpartum or those who are not at risk of HIV acquisition may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce the rates of HIV transmission from mothers to infants, improving health outcomes for families in Malawi.

How similar studies have performed: Previous research has shown success in implementing PrEP for HIV prevention in various populations, indicating that this approach has potential for effectiveness in similar contexts.

Where this research is happening

CHAPEL HILL, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.